Detalhe da pesquisa
1.
Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI.
Int J Mol Sci
; 23(23)2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499527
2.
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance.
J Neurol Neurosurg Psychiatry
; 92(12): 1305-1312, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34187866
3.
A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions.
Neuroradiology
; 63(12): 2035-2046, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34389887
4.
Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
Dement Geriatr Cogn Disord
; 49(6): 533-538, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626531
5.
Comprehensive strategy for proton chemical shift prediction: linear prediction with nonlinear corrections.
J Chem Inf Model
; 54(2): 419-30, 2014 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24455975
6.
The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis.
Mult Scler Relat Disord
; 85: 105517, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442501
7.
Circulating neurofilament is linked with morbid obesity, renal function, and brain density.
Sci Rep
; 12(1): 7841, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551210
8.
Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis.
Mult Scler Relat Disord
; 56: 103280, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34627002
9.
Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients.
Brain Behav
; 10(9): e01772, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32705821
10.
Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.
Ann Clin Transl Neurol
; 7(6): 903-910, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32441885
11.
Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study.
J Alzheimers Dis
; 75(3): 751-765, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32310181
12.
Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion.
J Neurol
; 267(1): 76-86, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31559531
13.
Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
J Neurol
; 267(1): 162-167, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595378
14.
Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.
J Alzheimers Dis
; 74(1): 277-286, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007958
15.
Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients.
J Alzheimers Dis
; 72(1): 127-137, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31561355
16.
Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.
J Alzheimers Dis
; 62(1): 165-174, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439329
17.
mNos2 deletion and human NOS2 replacement in Alzheimer disease models.
J Neuropathol Exp Neurol
; 73(8): 752-69, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003233